• Organigram’s corporate governance distinguishes the company in the cannabis industry
• OGI’s consistent financial performance positions it as an “anomaly in the Canadian cannabis market”
• The company recently upgraded from the TSX Venture Exchange to the Toronto Stock Exchange

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian licensed producer (LP) of premium-quality cannabis and extract-based products, is focused on producing high-quality, indoor-grown cannabis for patients and adult-recreational consumers. Championing that cause is Organigram’s leadership team, a group of seasoned professionals on the forefront of the global cannabis market who bring decades of experience in consumer-packaged goods, and pharma, including a CEO who held the same position at Tilray (NASDAQ: TLRY) before joining Organigram. In addition, the company’s fiscal discipline and execution, as well as its solid corporate governance foundation, distinguish it while some other LPs have met mild to severe consequences for regulatory breaches.

Bloomberg noted that OGI has a fully independent board of directors (excluding CEO Greg Engel), which is a rarity in the cannabis sector. The CEO sees good corporate governance as essential to a well-run pot company. “This is an industry that’s still very much moving from founders and executives being chairmen or multiple insiders on boards,” Engel told Bloomberg (http://ibn.fm/paDcr). “I think some of the challenges we’ve seen in the industry have been because of a lack of governance. You have to have independent governance that has oversight and holds management accountable.”

Along with the company’s impressive corporate governance comes its equally notable — and consistent — financial performance. This is likely due to its team’s adherence to fiscal discipline, something that can be difficult to find in this industry. Bloomberg noted that, with four quarters of profitability under its belt, Organigram Holdings is “an anomaly in the Canadian cannabis market.”

“Organigram has higher margins than most of its peers and one of the lowest costs per gram in the industry even though it grows indoors, generally considered the most expensive method of production,” the report stated. “Chief Executive Officer Greg Engel attributes this to its ability to get higher yields from its pot plants than companies that grow in greenhouses, as well as its automated packaging lines. No other large Canadian pot producer has managed to post such a long string of positive EBITDA.”

In addition, the company recently uplisted to the Toronto Stock Exchange (TSX) from the TSX Venture Exchange (TSX.V) under the symbol ‘OGI’.

“Graduating to the TSX is a significant milestone for us as a corporation,” Engel stated in a news release (http://ibn.fm/g63Gj). “Our stakeholders have an eye on this marketplace, and this graduation will broaden our reach within the investment community and encourage new investors to learn more about our business, our growth plans and corporate objectives.”

As a result of many of these developments, OGI has attracted significant attention. OGI was deemed a “compelling cannabis stock to buy in August” in a recent article distributed by The Motley Fool (http://ibn.fm/3jeGk). “I continue to view the long-term prospects for Organigram in a favorable light,” contributor Keith Speights wrote. “Other Canadian cannabis producers get a lot more hype right now, but Organigram could be a rising star that will attract plenty of attention in the near future. What I really like about Organigram is that its management team exercises fiscal discipline, which is kind of a rarity in the industry.”

Organigram’s primary facility is located in Moncton, New Brunswick, and the company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). Organigram has sales in all 10 Canadian provinces. The company has developed a portfolio of legal, adult-use recreational cannabis brands, including The Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. Additionally, it delivers industry-leading yields and maximizes quality-cannabis production at one of the lowest cultivation costs per gram* among publicly reporting Canadian LPs. Organigram is committed to translating operational excellence into strong financial results and return on investment for shareholders.

* Cultivation cost per gram is a non-IFRS measure. Please see the Company’s latest MD&A.

For more information, visit the company’s website at www.Investors.Organigram.ca

NOTE TO INVESTORS: The latest news and updates relating to OGI are available in the company’s newsroom at http://ibn.fm/OGRMF

• HTC Extraction Systems is an experienced and successful gas, liquids and biomass extractor and refiner using patented technologies for extraction and distillation processes
• HTC is building a 19,000-square-foot GMP Euro-compliant extraction, purification and distillation facility in Saskatchewan, and it is scouting to build another in the United States for hemp extraction services
• The company recently announced a common shares bought deal, whereby, subject to closing, $15 million in aggregate gross proceeds will be added to its bottom line

Extraction and distillation technology developer HTC Extraction Systems (TSX.V: HTC) is celebrating news that a group of underwriters has agreed, subject to due diligence completion, to purchase 15 million units of combined common shares and warrants to purchase further common shares, which, upon closing will amount to an influx of C$15 million in aggregate gross proceeds (http://ibn.fm/KhNtT).

HTC is drawing on a wealth of experience in extraction, purification and distillation and aims to become one of Canada’s largest cannabidiol (CBD) extractors and refiners as it builds a strategy for processing hemp biomass under an infrastructure that will include: a 19,000-square-foot GMP Euro-compliant extraction tolling facility on six acres of land southeast of Regina, Saskatchewan, and a large‐scale extraction facility at a yet-to-be-determined location in the United States, according to a company news release published in June (http://ibn.fm/SM4S1).

Over time, the company has developed and optimized proprietary systems for biomass, gas and liquid extraction, as well as for the distillation of ethanol and ethanol-based solvents used in the extraction process, and those resources provide the backbone of the company’s products and services.

“HTC will continue to drive the business model, where HTC will own physical assets at our extraction and purification facilities while serving the clean energy and hemp biomass industries,” HTC Executive Chairman Lionel Kambeitz stated in the news release. “Our business model calls for both participating equity ownership and tolling revenue.”

In Canada, HTC has an agreement for the 2019 growing season through which it will receive a projected five million kilograms of hemp biomass for extracting CBD full spectrum oil, using Health Canada-approved cultivars. HTC will receive a percentage of the distillate as payment of the tolling fee. Another tolling agreement with a 60,000-acre farm is pending for the 2019, 2020, 2021 and beyond seasons.

The company’s management plans for a facility in the United States that will adapt the scalable production, extraction, purification and distillation techniques that it has developed in Canada. Leveraging their relationships with successful farming leaders, management will draw on standard operating procedures (SOPs) and best practices in genetics, fertility, crop protection and ingredient sales with multi‐year contracts. HTC then intends to pursue plans for two annual crop rotations producing new high-CBD genetic varieties. The company is also continually evaluating potential synergistic technologies that could use distillate chromatography, chemical isolation and molecular distillation for production benefits.

HTC also intends to leverage its relationship with its related entity, Purely Canada Foods, to provide sales and distribution for its Ingredient CBD market under the brands of Purely Canada Hemp, Purely Canada CBD, Purely Canada Cannabinoids and Purely Canada THC. Purely Canada Foods is expected to develop multi-year ingredient supply contracts with its existing and new global food, beverage and animal food industry customers.

For more information, visit the company’s website at www.HTCExtraction.com

NOTE TO INVESTORS: The latest news and updates relating to HTC are available in the company’s newsroom at http://ibn.fm/HTC

• West Coast-based IONIC Brands has focused on vape products for recreational cannabis users, but a new agreement with a Washington-based partner grants it a foothold in the edibles and infused products sectors
• A second agreement between IONIC and an Australian Bluetooth technology producer will grant IONIC’s consumers access to vaporizer tech originally designed to help medical patients control the dosing of their medications
• The agreements mark an expansion of the cannabis holding company’s ability to provide secure dosing to recreational users
• IONIC expects to launch its newest vape product using the technology during the third quarter

Cannabis holding company IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) is expanding its sphere of operations with agreements that enhance the vape manufacturer’s competitiveness in the edibles and infused products markets, as well as technological developments that are expected to provide IONIC’s recreational consumers an innovative experience.

The company announced July 24 that it has completed the previously announced acquisition of Washington-based Natural Extractions Inc., which is doing business as Zoots Premium Cannabis Infused Edibles (http://ibn.fm/fsurk).

Zoots is an edibles company whose product line includes drops, gummies, energy shots and hard candies manufactured to offer consistent and reliable dosing. The products are currently available at licensed recreational cannabis retailers in Illinois, Washington, Colorado and Massachusetts.

“Our top-rated Ionic vaporizer pen targets consumers interested in luxury cannabis products that can be discreetly consumed which make Zoots edibles a natural fit for our brand strategy,” IONIC Brands Chairman and CEO John Gorst stated in a news release. “The Zoots acquisition expands our market segments to the popular edibles space and expands our distribution network throughout the United States.”

Zoots was founded by brothers Dan, Michael and Patrick Devlin, and Dan will continue as the chief operating officer under the agreement. The company’s products feature cannabis oil from Zoots’ proprietary Cypress Extraction system and offer serving sizes as low as 5 mg tetrahydrocannabinol (THC), making it easy for consumers to manage dosage and control over the drug’s effect.

IONIC’s exclusive Heads of Agreement with Lifespot Health Limited (ASX: LSH) is also a significant step toward managing drug dosing (http://ibn.fm/8LVz5). Lifespot’s Bluetooth-enabled vaporizers were developed to help medical patients efficiently manage dosing of their prescriptions for chronic illnesses and unexpected medical conditions on their personal digital devices, including smartphones, tablets and desktop computers. The tech can also be used effectively for recreational cannabis consumption by IONIC’s customers, once the firms complete binding joint venture and distribution agreements.

Lifespot’s software works with enhanced sensor technology to provide self-learning algorithms that make the company’s products user-friendly and analytical.

“Smartphone Bluetooth technology is the future of cannabis delivery and dosing,” Gorst added. “The company is ecstatic to offer consumers advanced delivery technology that, before this agreement, was only available to medical patients. Ionic’s launch and distribution of the Slim-line Vape is expected to start in Q3 2019 in Washington, Oregon, Nevada and California. The Slim-line Vape is the first Bluetooth enabled vaporizer and platform designed specifically for the use of cannabis.”

The agreement also provides a framework for the ongoing development and improvement of cannabis vaporizer technologies for the recreational cannabis vaporizer market. IONIC has completed a purchase order for an initial series of vaporizer and software technologies, and the company plans to begin shipping the product line during the third quarter.

For more information, visit the company’s website at www.IONIC.social

NOTE TO INVESTORS: The latest news and updates relating to IONKF are available in the company’s newsroom at http://ibn.fm/IONKF

• Marijuana Company of America saw its second quarter profits jump 633.5 percent over the previous year
• Sales through its hempSMART brand continue to show strength, with more than $100,000 in gross sales reported for the month of July
• MCOA’s growing international presence is playing a key role in its profits as well, with 33.5 percent of the quarter’s revenue derived from sales in other countries
• The company recently redesigned its website in order to enhance the free flow of information between administration and company investors

Innovative hemp and cannabis product cultivator Marijuana Company of America Inc. (OTCQB: MCOA) is celebrating large gains reported through its second quarter statement, showing a year-over-year increase of 633.5 percent in revenue and a gross margin of 86 percent on $179,441 in profits.

“Our second quarter of 2019 has been our most successful quarter to date at hempSMART. We continue to generate strong sales and momentum in Q3 with over $100K in gross sales for just the month of July,” CEO Donald Steinberg stated in announcing the results (http://ibn.fm/Nv8lg).

Steinberg said that the company expects to see demand for its uniquely formulated hempSMART cannabidiol (CBD) products to remain constant during the coming quarters, allowing the company to expand the brand throughout the United States and into Europe.

MCOA announced this summer that it had successfully introduced its products in Scotland and the Netherlands, selling out the items that company representatives had taken for the launch of its botanicals in those countries and enlisting new marketing associates (http://ibn.fm/EZQgN).

Total hempSMART revenues reached $208,580 for the quarter ended June 30, marking a significant increase from the $28,435 reported a year earlier. International sales made up 33.5 percent of the quarterly revenue. Gross sales for the first six months of the year were $323,390, with a $254,373 gross margin, as compared to $47,455 in sales and a $32,835 gross margin during the same period a year earlier.

The company’s net loss plummeted from $7.6 million to $419,624 for the quarter, as well.

MCOA recently announced that it has redesigned its website as part of its bid to increase transparency and clarity in its communications with investors (http://ibn.fm/gzMyC). The site will provide key information on the company’s portfolio of brands, farming projects, financial data, management, regulatory compliance and more.

“The new website presents a fresh design with enhanced functions focused on the company’s unique market position and its most recent developments that will be of value to current and prospective shareholders,” Steinberg added.

Marijuana Company of America’s key areas of focus are on the research and development of legal hemp-based consumer products, building an affiliate marketing program to promote its CBD products, leasing real property to separate business entities for the growth and sale of cannabis and expansion into ancillary areas of the legalized cannabis and hemp industry as opportunities develop.

For more information, visit the company’s websites at www.MarijuanaCompanyofAmerica.com and www.hempSMART.com

NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://ibn.fm/MCOA

• HTC announced entering into a letter agreement for a CAD$15 million bought deal private placement of units led by Canaccord Genuity Corp. on July 3, 2019 (subject to closing);
• HTC’s business model includes owning physical assets at extraction and purification facilities to serve the clean energy and hemp biomass industries;
• Hemp biomass tolling contracts with producers and hemp biomass providers are either signed or being negotiated in Canada and the U.S.;
• HTC will provide “local to grower” drying-to-biomass storage capability and transportation of dried biomass to HTC extraction facilities;
• HTC is constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility near Regina, Saskatchewan; and
• HTC has developed and optimized proprietary extraction and purification systems for biomass, gas and liquid extraction.

HTC Extraction Systems (TSX.V: HTC) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.

Advanced Extraction Technologies

For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:

• LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
• PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
• Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.

Delta Purification® Technology

HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:

• Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
• Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
• Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.

Hemp Biomass and Tolling Contracts

HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.

Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.

re3™ Technology

Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.

The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.

Sales and Offtake Agreements

HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.

Project Construction

HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.

Leadership

Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.

Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.

For more information, visit the company’s website at www.HTCExtraction.com

NOTE TO INVESTORS: The latest news and updates relating to HTC are available in the company’s newsroom at http://ibn.fm/HTC

• Combined adult-use and medical cannabis sales in Nevada reached nearly $530 million in 2018, the first full year of legal recreational sales
• The company’s acquisition of Vegas Valley Growers North in Las Vegas included production facilities, four state licenses and popular Nevada vape brand ‘Vegas M Stick’

National cannabis holding company IONIC Brands Corp. (CSE: IONC) (OTC: IONKF), formerly Zara Resources Inc., recently added to its multistate portfolio of award-winning cannabis brands with the purchase of Vegas Valley Growers North (“VVG”), a Las Vegas, Nevada, state-licensed cultivation and manufacturing firm for medical and recreational cannabis. The vertically-integrated, cash-flow positive opportunity brings IONIC additional projected 2019 revenue of $6.6 million, with expected gross profits of $3.1 million and EBITDA of $2 million, the company stated in a news release (http://ibn.fm/7jcbv).

“The Nevada cannabis market is one of the cornerstone markets in the U.S. for building cannabis brands,” IONIC Brands Chairman and CEO John Gorst stated in a news release. “With over 42 million visitors to Las Vegas per year, the VVG acquisition will provide our Ionic vape and Zoots edibles brands valuable exposure to national and international cannabis consumers.”

The VVG acquisition includes a leased 1,700-square-foot production facility and five state licenses for cultivation and manufacturing of both medical and recreational cannabis. VVG is also building a 60,000-square-foot manufacturing facility and has plans for a second 80,000-square-foot facility. Distribution licenses for both medicinal and recreational cannabis products are being processed by state regulators.

Also included in the acquisition was VVG’s popular Nevada vape brand, ‘Vegas M Stick’, which partners nicely with IONIC Brands’ flagship recreational branded product – a stylish and sophisticated premium vape pen line called ‘IONIC’ that has earned customer loyalty and a reputation as a consistent top 10 vape brand in Washington state.

“IONIC vape pens are the perfect complement to the Vegas M Stick. Together, these luxury brands are set to have a massive presence in the Nevada market for years to come,” VVG CEO Mitch Wilson added.

According to the Nevada Department of Taxation, combined adult-use and medical cannabis sales reached nearly $530 million in 2018 (the first full year of legal recreational sales) with the state collecting nearly $70 million in tax revenue. Nevada’s first year with a legal adult-use market exceeded revenue projections, and the state expects to see continued growth with revenues remaining strong in 2019, as the tax department detailed in a news release (http://ibn.fm/8Uztz).

Established in 2015, IONIC Brands has demonstrated its ability to expand and operate multiple cannabis concentrate consumer brands in markets across the western United States (http://ibn.fm/ot63a). The company continues to strategically expand nationwide in an effort to remain a leader of the highest-value segments in the cannabis market.

For more information, visit the company’s website at www.IONIC.social

NOTE TO INVESTORS: The latest news and updates relating to IONKF are available in the company’s newsroom at  http://ibn.fm/IONKF

• SHRG owns and manages a variety of businesses specializing in the direct-selling industry
• The company recently appointed Garrett McGrath as chief impact officer and Sylvia McGrath as chief experience officer of Elepreneurs, LLC
• Elepreneurs is a wholly owned subsidiary of Sharing Services

Sharing Services Global Corporation (OTCQB: SHRG) is a diversified holdings company that’s committed to reshaping how today’s direct-selling entrepreneurs succeed in the world of network marketing. SHRG recently announced the appointments of Garrett McGrath as chief impact officer and Sylvia McGrath as chief experience officer for Elepreneurs (http://ibn.fm/cR4bT). The two professionals bring decades of experience to Elepreneurs, adding qualitative value to SHRG’s noteworthy leadership team.

Elepreneurs LLC, a wholly owned subsidiary of Sharing Services (http://ibn.fm/9rd7k), is expected to benefit from the addition of Garrett McGrath, who adds years of network marketing experience. McGrath boasts three decades of network marketing experience and has built mammoth networks in firms consisting of more than 150,000 distributors spanning 21 countries. He is also a highly reputed keynote speaker, leadership trainer and field liaison, and he has served as the president of the Association of Network Marketing Professionals (ANMP) since 2012.

With 25 years of marketing experience in the direct-selling industry, Sylvia McGrath is a multitalented executive. She has served as corporate vice president of marketing for a network marketing firm and as vice president of sales and marketing for a Fortune 500 clientele design firm.

“Garrett and Sylvia are two of the most respected, admired, and effective leaders in the network-marketing industry today,” Elepreneurs President Keith Halls stated in a news release. “They have always led an energetic and experienced network marketing team, and we are grateful to have them as part of the family.”

Sharing Services CEO John “JT” Thatch noted that the two appointments should further propel the company’s growth trajectory. “We are very pleased that the McGraths have decided to join the executive management team of Elepreneurs as the company continues to grow since launching its first products in December 2017,” Thatch added. “These two individuals will add great value to the already experienced team that has helped us be successful thus far in the marketplace, which includes our incredible Elepreneurs in the field.”

Nearly 1,000 participants attended Elepreneurs’ first annual event, its Happiness Convention in Dallas, Texas. Enthusiastic Elepreneurs from the United States, Canada, Mexico, Singapore and Hong Kong participated in the milestone convention. Imminent keynote speakers and motivational leaders such as Shawn Achor and Les Brown discussed important points and provided guidance to the budding home entrepreneurs.

Headquartered in Plano, Texas, Sharing Services adheres to its proprietary Blue Ocean Strategy to promote market growth. The powerful strategy implements three keys focused on growing a robust international channel of home-based entrepreneurs, known as Elepreneurs, and supporting them through the direct-selling channel to produce 100 percent organic growth.

For more information, visit the company’s website at www.SHRGInc.com

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

• CannaPharmaRx is in the process of acquiring, funding and developing three significant cannabis cultivation sites in Ontario and British Columbia
• The company’s agreements with the facilities’ owners grant it access to cultivation sites that could return close to 300,000 pounds of product per year
• The global cannabis cultivation industry is expected to become a nearly $155 billion market by 2026

Real estate investment and early-stage pharmaceutical company CannaPharmaRx Inc. (OTC: CPMD) is advancing its plans to become a cannabis cultivator using proprietary formulation and drug delivery technology currently in development to expand in an industry that is evolving at an aggressive pace. Analysts at ResearchandMarkets.com measured global cannabis sales at $10.39 billion in 2017 and are predicting a CAGR of 35 percent to $154.82 billion by 2026 (http://ibn.fm/KcnKs).

During the past year, CannaPharmaRx has completed agreements that will grant it a 48,750-square-foot cannabis grow facility in Hanover, Ontario; a 60,000-square-foot cannabis cultivation and grow facility in Stevensville, Ontario; and a 759,000-square-foot cannabis grow facility in Okanagan Falls, British Columbia, once funding to complete construction of the facilities is established.

The Stevensville facility is the first of the projects to be completed, but final acquisition depends upon CannaPharmaRx’s strategy to obtain all of the facility owner’s stock. Additional purchases of stock from other shareholders in the company, GN Ventures Ltd., are expected to be completed this year.

The Hanover facility is the next furthest along in development at this point. Exterior construction of the building has been completed, but interior construction has yet to begin. Once the facility is completed, it will contain up to 20 separate growing rooms with a projected annual production capacity of 9,500 kilograms of cannabis (20,900 pounds), according to CannaPharmaRx (http://ibn.fm/cEefr). Completion of the build-out of the facility is expected to take an estimated 20 weeks.

The Hanover facility was acquired through an agreement with Alternative Medical Solutions Inc. (AMS) in November. AMS has filed a cultivation application with Health Canada, which requires completion of the building as part of a phased approach toward finalizing the license.

The Okanagan Falls facility is still in the early stages of construction. It was acquired through a securities purchase agreement with Sunniva Inc. for a 116-acre parcel of land. Plans for the facility call for a two-phase development. The first phase is to construct 458,000 square feet comprising eight separate growing rooms expected to produce 60,000 kilograms (120,000 pounds) of cannabis flower per year. The second phase would involve an additional 301,000 square feet with similar production estimates.

Completion of the phase one buildout is expected to take 12 months, once financing is finalized.

“We are excited to have reached an agreement to purchase this property from Sunniva,” CEO Dominic Colvin stated in a June news release (http://ibn.fm/YAi4C). “The acquisition and development of the Okanagan Falls property, combined with our Hanover, Ontario, property and ownership interest in GN Ventures Ltd., sets the stage for the next step in CannaPharmaRx’s growth strategy to become a significant player in the Canadian cannabis industry while continuing to strive to maximize shareholder value.”

CannaPharmaRx is also working toward a public listing on a Canadian stock exchange later this year (http://ibn.fm/35XYZ).

For more information, visit the company’s website at www.CannaPharmaRx.com

• Citing larger distributor and private-label orders, VPRB reported revenues of $1.58 million for Q2 2019
• The company also reported a 31 percent increase in sales
• VPRB attained an uplisting to the OCTQB Venture Market

VPR Brands LP (OTCQB: VPRB), a multi-vertical, tiered company in the cannabis space, has increased its sales significantly through larger distributor and private-label orders, growing its quarterly figure to $1.58 million for the three-month period ended June 30 to record a 31 percent increase over the same period of 2018. VPRB also reported a 31 percent year-over-year sales increase for the six months ended June 30, 2019 (http://ibn.fm/D1B97).

As the company’s sales jumped, VPRB also achieved an OTCQB uplisting, reflecting its current reporting status, as well as annual verification and management certification. The company noted that such a move helps build shareholder value and enhances liquidity and fair valuation (http://ibn.fm/4WE6y).

“The results of putting our newly raised capital to work in Q2 were increased sales and larger distributor and private-label orders, which are key components to our growth strategy and will allow the company to continue to increase revenues and scale the business going forward,” VPRB CEO Kevin Frija stated in a news release.

VPRB anticipates being able to decrease product costs as it reaches larger volume, allowing it to achieve its target 40 percent margins. “In the second quarter of 2019, VPR Brands was able to invest in expanding product lines and on hand inventory to be able to acquire new distributors‎ and better meet demand,” added VPRB COO Dan Hoff. “‎Launching our new variable voltage twist battery played a big part in gaining entry level product market share in the below $25.00 MSRP range.”

VPRB is innovating the vaping experience through its new product, HoneyStick Brand BeeBox Pro Device. This innovation is an integral part of the company’s growth strategy. The new unit enables users to monitor battery life on an LCD screen. The device is also power adjustable to permit dial-in intensity levels for vaping. The result is that users can have a customized experience, controlling cloud, taste and activation. “This is a must-have device for anyone who vapes both nicotine and cannabis, the best of both worlds,” noted Frija (http://ibn.fm/OeeH0).

Another component aiding the growth of VPRB is the depth of the company’s management experience. Frija has 29 years of experience in the areas of sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. COO Dan Hoff has been in the vaporizer and e-cigarette industry at Vapor Corp. since the company’s inception in 2007. He has been with VPRB since 2016. Senior sales executive Gary Rep joined VPRB in 2018 but worked for a decade as vice president of sales and marketing at his previous company. VPRB also has senior and experienced management in web design, graphics, importing, international sales and other team positions.

For more information, visit the company’s website at www.VPRBrands.com

NOTE TO INVESTORS: The latest news and updates relating to VPRB are available in the company’s newsroom at http://ibn.fm/VPRB

• Trxade Group is actively working to reverse a negative phenomenon known as ‘pharmacy deserts’ that is affecting many parts of the U.S.
• Trxade is providing a solution that empowers small, independent pharmacies by giving them access to competitive pricing and reliable supply options
• Due to the demand, Trxade Group is also working on new product offerings that will expand the predictive analytical capabilities of community-based and independent pharmacies

As independent pharmacy businesses struggle to overcome various challenges, the U.S. is facing a growing problem with the so-called ‘pharmacy deserts’ phenomenon, which results in entire areas left without pharmacy services. One of the main reasons that so many smaller, independent industry players close down shop is that they cannot successfully compete against large pharmaceutical chains. Companies like Trxade Group Inc. (OTCQB: TRXD) are working to reverse the trend.

Trxade Group is an integrated pharmaceutical services company that has developed a web-based purchasing platform for transactions between independent pharmacies and drug distributors. The system is characterized by an optimum buyer/seller pricing algorithm, information about product availability and predictive data analytics.

Of more than 65,000 pharmacy facilities operating in the U.S., 24,000 are independent. The aim of the Trxade’s platform is to support local, independent pharmacies through the identification of the best sourcing and pricing opportunities for prescription drugs.

Independent pharmacies struggle due to the large capacity of national and international drugstore chains. These chains acquire products in bulk, which means that their supplies are available at a reduced cost in comparison to what a smaller, independent pharmacy would get as a price quote.

Additionally, problems arise from the work of the pharmacy benefit managers (PMBs) who process claims. Currently, PMBs work for Medicare, Medicaid and commercial health plans with the intent to reduce benefits for the pharmacies to bring down expenses for insurers. The situation with state Medicaid patient coverage has become so troublesome that numerous independent pharmacies across the U.S. have had to discontinue operations.

Reports suggest that the absence of independent community pharmacies is harming patients. Local businesses are perceived as members of the community, and the pharmacists working at independent enterprises often go the extra mile to ensure the availability of important medications for elderly or disabled patients.

Trxade Group is constantly working to empower independent and community-based small pharmacies. Apart from its already established platform, TRXD is also planning the launch of new products in the near future.

New product offerings have been developed to address customer demand, offering increased data analytics capability and better inventory/cost management, as TRXD Chairman and CEO Suren Ajjarapu detailed in a news release.

TRXD’s network of independent pharmacies is also growing rapidly. By the end of June 2019, the company had registered the addition of 390 new independent pharmacies to its platform. This number represents an increase of 24 percent on a quarterly basis and of 137 percent on an annual basis.

The company’s current trading software membership has reached the impressive 10,500 pharmacies milestone. This massive number and the growth registered so far in 2019 have TRXD optimistic about the future.

For more information, visit the company’s website at www.TrxadeGroup.com

NOTE TO INVESTORS: The latest news and updates relating to TRXD are available in the company’s newsroom at http://ibn.fm/TRXD